Levofloxacin based triple therapy as a second-line treatment after failure of helicobacter pylori eradication with standard triple therapy.

@article{Watanabe2003LevofloxacinBT,
  title={Levofloxacin based triple therapy as a second-line treatment after failure of helicobacter pylori eradication with standard triple therapy.},
  author={Yoshinori Watanabe and Nobuo Aoyama and Daisuke Shirasaka and Shuji Maekawa and Kohei Kuroda and Ikuya Miki and Masaaki Kachi and Masako Fukuda and Casmir Marwa Wambura and Takao Tamura and Masato Kasuga},
  journal={Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver},
  year={2003},
  volume={35 10},
  pages={
          711-5
        }
}
BACKGROUND Successful eradication of Helicobacter pylori infection after failure of standard triple therapy is difficult. The efficacy and safety of levofloxacin based triple therapy as a first-line therapy has-been studied. AIMS The aim was to evaluate the efficacy and tolerability of levofloxacin based therapy after a failed standard triple therapy. PATIENTS We conducted a prospective, uncontrolled study of a consecutive series of 33 patients who failed eradication with 1 week of… CONTINUE READING
Highly Cited
This paper has 49 citations. REVIEW CITATIONS

Citations

Publications citing this paper.
Showing 1-10 of 24 citations